Relationship of Prostate-Specific Antigen and Prostate Volume in Korean Men with Biopsy-Proven Benign Prostatic Hyperplasia

Urology

Volumn 71, Issue 3, 2008, Pages 395-398

  Lee, Sang Eun ^a   Chung, Jae Seung ^a   Han, Byung Kyu ^a   Moon, Ki Hyuk ^a   Hwang, Sung Il ^a   Lee, Hak Jong ^a   Choe, Gheeyoung ^a   Hong, Sung Kyu ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KOREA; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE HYPERTROPHY; TRANSRECTAL ULTRASONOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; HUMANS; KOREA; MALE; MIDDLE AGED; ORGAN SIZE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA;

EID: 40649102435     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.10.019     Document Type: Article

References (19)

1. Wang M.C., Valenzuela L.A., Murphy G.P., et al. Purification of a human prostate specific antigen. Invest Urol 17 (1979) 159-163
2. Roehrborn C.G., Boyle P., Gould A.L., et al. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 53 (1999) 581-589
3. Roehrborn C.G., McConnell J.D., Lieber M., et al. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group. Urology 53 (1999) 473-480
4. Jacobsen S.J., Jacobson D.J., Girman C.J., et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol 158 (1997) 481-487
5. Roehrborn C.G., Boyle P., Bergner D., et al. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group. Urology 54 (1999) 662-669
6. Roehrborn C.G., Boyle P., Nickel J.C., et al. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology 60 (2002) 434-441
7. Gupta A., Aragaki C., Gotoh M., et al. Relationship between prostate specific antigen and indexes of prostate volume in Japanese men. J Urol 173 (2005) 503-506
8. Chang Y.L., Lin A.T., Chen K.K., et al. Correlation between serum prostate specific antigen and prostate volume in Taiwanese men with biopsy proven benign prostatic hyperplasia. J Urol 176 (2006) 196-199
9. Hochberg D.A., Armenakas N.A., and Fracchia J.A. Relationship of prostate-specific antigen and prostate volume in patients with biopsy proven benign prostatic hyperplasia. Prostate 45 (2000) 315-319
10. Masumori N., Tsukamoto T., Kumamoto Y., et al. Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: results of community based studies in 2 countries. J Urol 155 (1996) 1324-1327
11. Oesterling J.E., Kumamoto Y., Tsukamoto T., et al. Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br J Urol 75 (1995) 347-353
12. Shim H.B., Lee J.K., Jung T.Y., and Ku J.H. Serum prostate specific antigens a predictor of prostate volume in Korean men with lower urinary tract symptoms. Prostate Cancer Prostatic Dis 10 (2007) 143-148
13. Berry S.J., Coffey D.S., and Ewing L.L. Effects of aging on prostate growth in beagles. Am J Physiol 250 (1986) R1039-R1046
14. Walsh P.C., Madden J.D., Harrod M.J., et al. Familial incomplete male pseudohermaphroditism, type 2: decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med 291 (1974) 944-949
15. Roberts R.O., Bergstralh E.J., Cunningham J.M., et al. Androgen receptor gene polymorphisms and increased risk of urologic measures of benign prostatic hyperplasia. Am J Epidemiol 159 (2004) 269-276
16. Wu A.H., Whittemore A.S., Kolonel L.N., et al. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev 4 (1995) 735-741
17. Platz E.A., Rimm E.B., Willett W.C., et al. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Natl Cancer Inst 92 (2000) 2009-2017
18. Lepor H., Shapiro E., Wang B., et al. Comparison of the cellular composition of benign prostatic hyperplasia in Chinese and caucasian-american men. Urology 47 (1996) 38-42
19. Aoki Y., Arai Y., Maeda H., et al. Racial differences in cellular composition of benign prostatic hyperplasia. Prostate 49 (2001) 243-250